| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gonorrhea | 14 | 2020 | 31 | 5.120 |
Why?
|
| Primary Health Care | 20 | 2023 | 283 | 4.510 |
Why?
|
| Neisseria gonorrhoeae | 9 | 2020 | 21 | 3.190 |
Why?
|
| Manitoba | 40 | 2024 | 40 | 3.070 |
Why?
|
| Family Practice | 8 | 2021 | 43 | 2.390 |
Why?
|
| Canada | 27 | 2023 | 121 | 2.340 |
Why?
|
| Humans | 165 | 2024 | 34853 | 2.280 |
Why?
|
| Healthcare Disparities | 8 | 2021 | 446 | 2.100 |
Why?
|
| Syphilis | 5 | 2023 | 27 | 2.030 |
Why?
|
| Radiosurgery | 12 | 2019 | 61 | 1.950 |
Why?
|
| Female | 109 | 2024 | 19873 | 1.910 |
Why?
|
| Adult | 83 | 2024 | 11034 | 1.890 |
Why?
|
| Chronic Disease | 6 | 2021 | 469 | 1.850 |
Why?
|
| Middle Aged | 78 | 2023 | 9642 | 1.840 |
Why?
|
| Male | 104 | 2024 | 18870 | 1.800 |
Why?
|
| Mental Disorders | 7 | 2021 | 285 | 1.800 |
Why?
|
| Hawaii | 42 | 2024 | 1878 | 1.800 |
Why?
|
| Leptospirosis | 9 | 2012 | 26 | 1.780 |
Why?
|
| Population Surveillance | 13 | 2021 | 231 | 1.730 |
Why?
|
| Income | 7 | 2023 | 135 | 1.690 |
Why?
|
| Anti-Bacterial Agents | 7 | 2020 | 355 | 1.670 |
Why?
|
| Aged | 59 | 2021 | 6448 | 1.620 |
Why?
|
| Prenatal Care | 4 | 2021 | 74 | 1.520 |
Why?
|
| Indians, North American | 3 | 2019 | 145 | 1.520 |
Why?
|
| Leptospira | 7 | 2012 | 22 | 1.470 |
Why?
|
| Hospitalization | 8 | 2021 | 370 | 1.460 |
Why?
|
| Drug Resistance, Bacterial | 6 | 2020 | 78 | 1.450 |
Why?
|
| Azithromycin | 4 | 2020 | 8 | 1.390 |
Why?
|
| Retrospective Studies | 33 | 2024 | 1961 | 1.350 |
Why?
|
| Young Adult | 38 | 2024 | 4012 | 1.340 |
Why?
|
| Health Services, Indigenous | 2 | 2019 | 20 | 1.330 |
Why?
|
| Pelvic Inflammatory Disease | 3 | 2018 | 20 | 1.300 |
Why?
|
| Ceftriaxone | 5 | 2020 | 11 | 1.250 |
Why?
|
| Disaster Planning | 3 | 2020 | 51 | 1.250 |
Why?
|
| Reimbursement, Incentive | 2 | 2018 | 11 | 1.210 |
Why?
|
| Physicians, Family | 6 | 2023 | 19 | 1.180 |
Why?
|
| Adolescent | 36 | 2024 | 5035 | 1.130 |
Why?
|
| Sexually Transmitted Diseases | 4 | 2023 | 165 | 1.120 |
Why?
|
| Aged, 80 and over | 27 | 2021 | 2333 | 1.070 |
Why?
|
| Mental Health Services | 3 | 2020 | 108 | 1.060 |
Why?
|
| Child | 24 | 2024 | 2875 | 1.060 |
Why?
|
| Interprofessional Relations | 5 | 2023 | 48 | 1.050 |
Why?
|
| Prevalence | 22 | 2024 | 1425 | 1.050 |
Why?
|
| Hepatitis C | 3 | 2017 | 120 | 1.040 |
Why?
|
| Ambulatory Care | 3 | 2021 | 76 | 1.010 |
Why?
|
| Patient Care Team | 3 | 2020 | 44 | 0.940 |
Why?
|
| Quality of Health Care | 3 | 2022 | 136 | 0.930 |
Why?
|
| Chlamydia Infections | 5 | 2014 | 196 | 0.920 |
Why?
|
| Infant | 16 | 2024 | 1014 | 0.900 |
Why?
|
| Child, Preschool | 18 | 2024 | 1318 | 0.890 |
Why?
|
| Prescriptions | 1 | 2022 | 17 | 0.860 |
Why?
|
| Bioterrorism | 3 | 2006 | 18 | 0.860 |
Why?
|
| Vaccination | 5 | 2024 | 259 | 0.860 |
Why?
|
| Electronic Health Records | 3 | 2017 | 65 | 0.840 |
Why?
|
| Influenza, Human | 4 | 2021 | 79 | 0.840 |
Why?
|
| Comorbidity | 12 | 2021 | 606 | 0.830 |
Why?
|
| Health Status Indicators | 1 | 2021 | 73 | 0.810 |
Why?
|
| Pregnancy Outcome | 3 | 2021 | 90 | 0.810 |
Why?
|
| Health Services Accessibility | 6 | 2019 | 531 | 0.800 |
Why?
|
| Cohort Studies | 19 | 2023 | 1422 | 0.790 |
Why?
|
| Aedes | 1 | 2020 | 20 | 0.780 |
Why?
|
| Poverty | 3 | 2023 | 316 | 0.760 |
Why?
|
| Health Knowledge, Attitudes, Practice | 8 | 2015 | 790 | 0.760 |
Why?
|
| Mass Screening | 6 | 2017 | 427 | 0.760 |
Why?
|
| Hospitals | 2 | 2020 | 86 | 0.760 |
Why?
|
| Patient Simulation | 1 | 2020 | 13 | 0.750 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 176 | 0.750 |
Why?
|
| Mothers | 2 | 2019 | 164 | 0.740 |
Why?
|
| Prostatic Neoplasms | 4 | 2019 | 794 | 0.730 |
Why?
|
| Cross-Sectional Studies | 16 | 2024 | 2561 | 0.710 |
Why?
|
| Radiography | 2 | 2018 | 75 | 0.710 |
Why?
|
| Cervix Uteri | 1 | 2019 | 43 | 0.700 |
Why?
|
| Treponema pallidum | 1 | 2019 | 5 | 0.700 |
Why?
|
| Skin Ulcer | 1 | 2019 | 6 | 0.690 |
Why?
|
| Infant, Newborn | 10 | 2024 | 871 | 0.690 |
Why?
|
| Penile Diseases | 1 | 2019 | 8 | 0.690 |
Why?
|
| Cause of Death | 4 | 2020 | 154 | 0.690 |
Why?
|
| Physicians | 5 | 2015 | 148 | 0.680 |
Why?
|
| Community Health Services | 2 | 2019 | 175 | 0.680 |
Why?
|
| Attitude of Health Personnel | 8 | 2020 | 186 | 0.680 |
Why?
|
| Risk Factors | 18 | 2024 | 3414 | 0.670 |
Why?
|
| Community Health Centers | 3 | 2018 | 45 | 0.670 |
Why?
|
| Treatment Outcome | 14 | 2020 | 1349 | 0.660 |
Why?
|
| Fractures, Comminuted | 1 | 2018 | 1 | 0.650 |
Why?
|
| Radius Fractures | 1 | 2018 | 3 | 0.650 |
Why?
|
| Wrist Joint | 1 | 2018 | 3 | 0.650 |
Why?
|
| Health Policy | 2 | 2017 | 149 | 0.640 |
Why?
|
| Quality Indicators, Health Care | 1 | 2018 | 40 | 0.640 |
Why?
|
| Osteoporosis | 1 | 2018 | 32 | 0.640 |
Why?
|
| Yoga | 1 | 2018 | 27 | 0.640 |
Why?
|
| Pediatrics | 3 | 2021 | 66 | 0.630 |
Why?
|
| Contact Tracing | 1 | 2017 | 17 | 0.630 |
Why?
|
| Holistic Health | 1 | 2017 | 11 | 0.620 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2017 | 30 | 0.620 |
Why?
|
| Forms and Records Control | 1 | 2017 | 5 | 0.620 |
Why?
|
| Psychotropic Drugs | 1 | 2017 | 13 | 0.620 |
Why?
|
| Data Collection | 3 | 2014 | 188 | 0.600 |
Why?
|
| Pregnancy Complications | 2 | 2017 | 132 | 0.600 |
Why?
|
| Pregnancy | 12 | 2023 | 1503 | 0.600 |
Why?
|
| Veterans | 1 | 2018 | 115 | 0.600 |
Why?
|
| Diabetes Mellitus | 4 | 2014 | 465 | 0.590 |
Why?
|
| Health Personnel | 3 | 2018 | 200 | 0.590 |
Why?
|
| Health Surveys | 5 | 2018 | 358 | 0.570 |
Why?
|
| Cardiovascular Diseases | 4 | 2019 | 628 | 0.570 |
Why?
|
| Microbial Sensitivity Tests | 7 | 2018 | 203 | 0.560 |
Why?
|
| Socioeconomic Factors | 12 | 2022 | 1003 | 0.550 |
Why?
|
| Mammography | 1 | 2017 | 176 | 0.550 |
Why?
|
| HIV Infections | 7 | 2023 | 2207 | 0.550 |
Why?
|
| Referral and Consultation | 2 | 2014 | 110 | 0.550 |
Why?
|
| Community-Acquired Infections | 2 | 2013 | 24 | 0.540 |
Why?
|
| Arthritis, Rheumatoid | 3 | 2021 | 52 | 0.540 |
Why?
|
| Liver Neoplasms | 5 | 2013 | 195 | 0.540 |
Why?
|
| Neoplasm Metastasis | 6 | 2018 | 211 | 0.520 |
Why?
|
| Regional Health Planning | 2 | 2004 | 14 | 0.510 |
Why?
|
| Neoplasms | 4 | 2012 | 1033 | 0.510 |
Why?
|
| Specialization | 1 | 2014 | 21 | 0.510 |
Why?
|
| Delivery of Health Care | 7 | 2023 | 254 | 0.510 |
Why?
|
| Battered Women | 1 | 2014 | 11 | 0.510 |
Why?
|
| Staphylococcal Infections | 2 | 2013 | 64 | 0.510 |
Why?
|
| Multiple Sclerosis | 3 | 2021 | 43 | 0.510 |
Why?
|
| Public Health | 4 | 2017 | 348 | 0.500 |
Why?
|
| Societies, Medical | 1 | 2014 | 62 | 0.500 |
Why?
|
| Radiotherapy, Conformal | 1 | 2014 | 2 | 0.490 |
Why?
|
| Patient-Centered Care | 3 | 2021 | 51 | 0.490 |
Why?
|
| Health Care Surveys | 6 | 2017 | 136 | 0.490 |
Why?
|
| Inflammatory Bowel Diseases | 3 | 2021 | 85 | 0.480 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2013 | 17 | 0.480 |
Why?
|
| Coffee | 1 | 2013 | 20 | 0.480 |
Why?
|
| Practice Guidelines as Topic | 3 | 2019 | 187 | 0.470 |
Why?
|
| Needs Assessment | 4 | 2020 | 159 | 0.470 |
Why?
|
| Preventive Health Services | 2 | 2023 | 61 | 0.460 |
Why?
|
| Radiation Injuries | 3 | 2010 | 23 | 0.460 |
Why?
|
| Violence | 1 | 2014 | 126 | 0.460 |
Why?
|
| Clinical Competence | 3 | 2018 | 124 | 0.450 |
Why?
|
| Carcinoma | 1 | 2014 | 94 | 0.450 |
Why?
|
| Breast Feeding | 4 | 2021 | 105 | 0.450 |
Why?
|
| Disease Outbreaks | 5 | 2011 | 155 | 0.450 |
Why?
|
| Colorectal Neoplasms | 5 | 2018 | 413 | 0.450 |
Why?
|
| Myocardial Ischemia | 3 | 2019 | 72 | 0.440 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2018 | 343 | 0.440 |
Why?
|
| Interpersonal Relations | 1 | 2014 | 198 | 0.440 |
Why?
|
| Hypoglycemic Agents | 1 | 2014 | 152 | 0.440 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2014 | 143 | 0.430 |
Why?
|
| Pneumonia, Viral | 1 | 2013 | 70 | 0.430 |
Why?
|
| Universities | 3 | 2020 | 363 | 0.420 |
Why?
|
| Incidence | 11 | 2021 | 882 | 0.420 |
Why?
|
| Bacteremia | 1 | 2012 | 31 | 0.420 |
Why?
|
| Biomedical Research | 1 | 2016 | 371 | 0.410 |
Why?
|
| Urethritis | 1 | 2011 | 2 | 0.410 |
Why?
|
| Education, Distance | 2 | 2023 | 40 | 0.410 |
Why?
|
| Hepatitis B | 2 | 2024 | 39 | 0.410 |
Why?
|
| Diagnostic Errors | 1 | 2011 | 18 | 0.400 |
Why?
|
| Ontario | 7 | 2023 | 27 | 0.400 |
Why?
|
| Neisseria meningitidis | 1 | 2011 | 16 | 0.400 |
Why?
|
| Ciprofloxacin | 2 | 2017 | 15 | 0.400 |
Why?
|
| DNA, Bacterial | 1 | 2012 | 184 | 0.400 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2019 | 77 | 0.390 |
Why?
|
| Health Promotion | 5 | 2023 | 588 | 0.380 |
Why?
|
| Neoplasm Recurrence, Local | 7 | 2019 | 133 | 0.370 |
Why?
|
| Heterosexuality | 2 | 2013 | 85 | 0.370 |
Why?
|
| Registries | 2 | 2017 | 330 | 0.350 |
Why?
|
| Atrial Fibrillation | 2 | 2020 | 105 | 0.350 |
Why?
|
| Appendicitis | 1 | 2008 | 18 | 0.340 |
Why?
|
| Prostate | 2 | 2019 | 136 | 0.320 |
Why?
|
| Child Welfare | 3 | 2017 | 34 | 0.320 |
Why?
|
| Cooperative Behavior | 2 | 2020 | 205 | 0.320 |
Why?
|
| Risk Assessment | 6 | 2019 | 727 | 0.320 |
Why?
|
| Hormone Replacement Therapy | 1 | 2007 | 41 | 0.310 |
Why?
|
| Occupational Exposure | 3 | 2019 | 67 | 0.310 |
Why?
|
| Methicillin Resistance | 1 | 2007 | 12 | 0.310 |
Why?
|
| Multivariate Analysis | 6 | 2018 | 570 | 0.310 |
Why?
|
| Disease Notification | 2 | 2018 | 5 | 0.310 |
Why?
|
| Carrier State | 1 | 2007 | 32 | 0.310 |
Why?
|
| United States | 11 | 2021 | 3894 | 0.310 |
Why?
|
| Urban Population | 4 | 2014 | 318 | 0.310 |
Why?
|
| Age Factors | 7 | 2017 | 1007 | 0.300 |
Why?
|
| Influenza Vaccines | 2 | 2021 | 50 | 0.300 |
Why?
|
| Testosterone | 1 | 2007 | 181 | 0.290 |
Why?
|
| Child Abuse | 2 | 2017 | 60 | 0.290 |
Why?
|
| Staphylococcus aureus | 1 | 2007 | 80 | 0.290 |
Why?
|
| Health Status Disparities | 4 | 2018 | 583 | 0.290 |
Why?
|
| Health Status | 4 | 2017 | 356 | 0.290 |
Why?
|
| Nurses | 1 | 2006 | 44 | 0.290 |
Why?
|
| Dentists | 1 | 2006 | 10 | 0.290 |
Why?
|
| Physician-Patient Relations | 4 | 2017 | 118 | 0.290 |
Why?
|
| Breast Neoplasms | 1 | 2017 | 1426 | 0.280 |
Why?
|
| Education, Veterinary | 1 | 2006 | 2 | 0.280 |
Why?
|
| Depressive Disorder | 2 | 2018 | 166 | 0.280 |
Why?
|
| Follow-Up Studies | 9 | 2019 | 964 | 0.280 |
Why?
|
| Educational Status | 3 | 2022 | 295 | 0.280 |
Why?
|
| Regression Analysis | 2 | 2017 | 429 | 0.280 |
Why?
|
| Lung Neoplasms | 4 | 2018 | 336 | 0.280 |
Why?
|
| Heart Failure | 4 | 2020 | 230 | 0.270 |
Why?
|
| Students | 2 | 2007 | 452 | 0.270 |
Why?
|
| Substance Abuse, Intravenous | 2 | 2017 | 123 | 0.260 |
Why?
|
| Public Housing | 2 | 2015 | 15 | 0.260 |
Why?
|
| Coronary Angiography | 3 | 2020 | 92 | 0.250 |
Why?
|
| Demography | 2 | 2022 | 167 | 0.250 |
Why?
|
| Anxiety Disorders | 2 | 2018 | 281 | 0.250 |
Why?
|
| Predictive Value of Tests | 3 | 2005 | 424 | 0.250 |
Why?
|
| Juvenile Delinquency | 1 | 2004 | 41 | 0.250 |
Why?
|
| Hepatitis B, Chronic | 1 | 2024 | 11 | 0.250 |
Why?
|
| Acupuncture Therapy | 1 | 2003 | 13 | 0.230 |
Why?
|
| Prognosis | 8 | 2021 | 707 | 0.230 |
Why?
|
| Medication Adherence | 2 | 2022 | 165 | 0.230 |
Why?
|
| Urinary Tract Infections | 1 | 2003 | 36 | 0.230 |
Why?
|
| Prisoners | 1 | 2004 | 83 | 0.220 |
Why?
|
| Anti-Infective Agents | 1 | 2003 | 62 | 0.220 |
Why?
|
| Survival Rate | 8 | 2018 | 310 | 0.220 |
Why?
|
| Schools | 2 | 2022 | 229 | 0.220 |
Why?
|
| Social Class | 2 | 2014 | 228 | 0.220 |
Why?
|
| Nurse Practitioners | 1 | 2002 | 14 | 0.220 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 430 | 0.220 |
Why?
|
| Occult Blood | 2 | 2012 | 25 | 0.210 |
Why?
|
| Seasons | 2 | 2014 | 112 | 0.210 |
Why?
|
| Patient Compliance | 3 | 2012 | 202 | 0.210 |
Why?
|
| False Positive Reactions | 2 | 2016 | 25 | 0.210 |
Why?
|
| Health Care Costs | 2 | 2020 | 69 | 0.210 |
Why?
|
| Infant, Low Birth Weight | 2 | 2021 | 37 | 0.210 |
Why?
|
| Syphilis, Congenital | 1 | 2021 | 1 | 0.210 |
Why?
|
| Sexually Transmitted Diseases, Bacterial | 3 | 2017 | 8 | 0.210 |
Why?
|
| Residence Characteristics | 2 | 2015 | 301 | 0.210 |
Why?
|
| Morphine | 1 | 2022 | 80 | 0.210 |
Why?
|
| Brachial Plexus | 1 | 2021 | 3 | 0.200 |
Why?
|
| Birth Injuries | 1 | 2021 | 9 | 0.200 |
Why?
|
| Age Distribution | 5 | 2021 | 223 | 0.200 |
Why?
|
| Mosquito Control | 1 | 2020 | 8 | 0.200 |
Why?
|
| Qualitative Research | 2 | 2020 | 393 | 0.200 |
Why?
|
| Breeding | 1 | 2020 | 21 | 0.200 |
Why?
|
| Depression | 2 | 2018 | 664 | 0.200 |
Why?
|
| Health Resources | 1 | 2021 | 32 | 0.190 |
Why?
|
| Hypospadias | 1 | 2020 | 3 | 0.190 |
Why?
|
| Patient Care Management | 1 | 2020 | 6 | 0.190 |
Why?
|
| Sleep Apnea, Central | 1 | 2020 | 4 | 0.190 |
Why?
|
| Atrial Flutter | 1 | 2020 | 7 | 0.190 |
Why?
|
| Organizational Case Studies | 1 | 2020 | 29 | 0.190 |
Why?
|
| Technology Assessment, Biomedical | 1 | 2020 | 6 | 0.190 |
Why?
|
| Community Health Planning | 1 | 2020 | 35 | 0.190 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2020 | 33 | 0.190 |
Why?
|
| British Columbia | 4 | 2023 | 9 | 0.190 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2021 | 99 | 0.190 |
Why?
|
| Agricultural Workers' Diseases | 1 | 2019 | 2 | 0.180 |
Why?
|
| Linear Models | 2 | 2018 | 253 | 0.180 |
Why?
|
| Occupational Health | 1 | 2019 | 19 | 0.180 |
Why?
|
| Students, Nursing | 1 | 2020 | 31 | 0.180 |
Why?
|
| Hysterectomy | 1 | 2019 | 29 | 0.180 |
Why?
|
| Office Visits | 3 | 2021 | 22 | 0.180 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2019 | 1 | 0.180 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2019 | 50 | 0.180 |
Why?
|
| Antihypertensive Agents | 1 | 2022 | 284 | 0.180 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2019 | 64 | 0.180 |
Why?
|
| Pesticides | 1 | 2019 | 44 | 0.180 |
Why?
|
| Program Evaluation | 2 | 2017 | 316 | 0.170 |
Why?
|
| Chancre | 1 | 2019 | 1 | 0.170 |
Why?
|
| Penicillin G Benzathine | 1 | 2019 | 1 | 0.170 |
Why?
|
| Scrotum | 1 | 2019 | 4 | 0.170 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 147 | 0.170 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2019 | 60 | 0.170 |
Why?
|
| Databases, Factual | 3 | 2021 | 288 | 0.170 |
Why?
|
| Afghan Campaign 2001- | 1 | 2018 | 6 | 0.170 |
Why?
|
| Biopsy | 1 | 2019 | 151 | 0.160 |
Why?
|
| Penis | 1 | 2019 | 72 | 0.160 |
Why?
|
| Israel | 1 | 2018 | 18 | 0.160 |
Why?
|
| Rheumatic Fever | 1 | 2018 | 9 | 0.160 |
Why?
|
| Geriatrics | 1 | 2018 | 51 | 0.160 |
Why?
|
| Databases as Topic | 1 | 2017 | 18 | 0.160 |
Why?
|
| Cost of Illness | 1 | 2018 | 79 | 0.160 |
Why?
|
| Penicillins | 1 | 2017 | 12 | 0.160 |
Why?
|
| Postnatal Care | 1 | 2017 | 12 | 0.160 |
Why?
|
| Tetracycline | 1 | 2017 | 17 | 0.160 |
Why?
|
| Secondary Prevention | 1 | 2017 | 37 | 0.160 |
Why?
|
| Internet | 2 | 2017 | 204 | 0.160 |
Why?
|
| Needle-Exchange Programs | 1 | 2017 | 7 | 0.160 |
Why?
|
| Skin | 1 | 2019 | 173 | 0.160 |
Why?
|
| beta-Lactamases | 1 | 2017 | 33 | 0.160 |
Why?
|
| Bipolar Disorder | 1 | 2018 | 46 | 0.160 |
Why?
|
| Immunization | 1 | 2017 | 90 | 0.160 |
Why?
|
| Immune System Diseases | 1 | 2017 | 20 | 0.150 |
Why?
|
| Health Services Needs and Demand | 2 | 2012 | 143 | 0.150 |
Why?
|
| Combined Modality Therapy | 2 | 2017 | 142 | 0.150 |
Why?
|
| House Calls | 1 | 2017 | 8 | 0.150 |
Why?
|
| Primary Prevention | 1 | 2017 | 57 | 0.150 |
Why?
|
| Family Therapy | 1 | 2017 | 18 | 0.150 |
Why?
|
| Rectal Neoplasms | 1 | 2017 | 13 | 0.150 |
Why?
|
| Risk | 2 | 2018 | 256 | 0.150 |
Why?
|
| Respiratory Tract Diseases | 2 | 2014 | 25 | 0.150 |
Why?
|
| Computers | 1 | 2017 | 27 | 0.150 |
Why?
|
| Micronesia | 2 | 2009 | 87 | 0.150 |
Why?
|
| Syphilis Serodiagnosis | 1 | 2016 | 7 | 0.150 |
Why?
|
| Injections, Intramuscular | 1 | 2016 | 20 | 0.150 |
Why?
|
| Anti-HIV Agents | 1 | 2021 | 394 | 0.150 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 217 | 0.150 |
Why?
|
| Palliative Care | 1 | 2017 | 52 | 0.150 |
Why?
|
| Premature Birth | 1 | 2018 | 71 | 0.150 |
Why?
|
| Adolescent Health Services | 1 | 2017 | 27 | 0.150 |
Why?
|
| Quality of Life | 1 | 2021 | 459 | 0.150 |
Why?
|
| Sexual Behavior | 4 | 2023 | 587 | 0.150 |
Why?
|
| Immunoenzyme Techniques | 1 | 2016 | 105 | 0.150 |
Why?
|
| Child Health Services | 1 | 2017 | 41 | 0.150 |
Why?
|
| Terminal Care | 1 | 2017 | 47 | 0.150 |
Why?
|
| Sex Factors | 3 | 2017 | 859 | 0.150 |
Why?
|
| Depression, Postpartum | 1 | 2016 | 10 | 0.140 |
Why?
|
| Competency-Based Education | 1 | 2016 | 9 | 0.140 |
Why?
|
| Whole-Body Irradiation | 2 | 2006 | 8 | 0.140 |
Why?
|
| Stereotaxic Techniques | 2 | 2006 | 20 | 0.140 |
Why?
|
| Rural Population | 3 | 2021 | 253 | 0.140 |
Why?
|
| Psychometrics | 1 | 2018 | 292 | 0.140 |
Why?
|
| Child Development | 1 | 2017 | 84 | 0.140 |
Why?
|
| Pregnancy in Adolescence | 1 | 2016 | 33 | 0.140 |
Why?
|
| Lipids | 1 | 2017 | 222 | 0.140 |
Why?
|
| Asia | 3 | 2020 | 74 | 0.140 |
Why?
|
| Odds Ratio | 1 | 2017 | 517 | 0.130 |
Why?
|
| Logistic Models | 4 | 2017 | 894 | 0.130 |
Why?
|
| Decision Making | 1 | 2017 | 189 | 0.130 |
Why?
|
| Organization and Administration | 1 | 2014 | 1 | 0.130 |
Why?
|
| Airway Obstruction | 1 | 2014 | 9 | 0.130 |
Why?
|
| Indonesia | 1 | 2014 | 10 | 0.130 |
Why?
|
| Guidelines as Topic | 2 | 2012 | 50 | 0.130 |
Why?
|
| Health Services Research | 1 | 2015 | 133 | 0.130 |
Why?
|
| Research Support as Topic | 1 | 2014 | 75 | 0.130 |
Why?
|
| Neoplasm Staging | 3 | 2018 | 269 | 0.130 |
Why?
|
| Sentinel Surveillance | 1 | 2014 | 20 | 0.120 |
Why?
|
| Guideline Adherence | 2 | 2012 | 82 | 0.120 |
Why?
|
| Mood Disorders | 1 | 2014 | 43 | 0.120 |
Why?
|
| Proportional Hazards Models | 3 | 2020 | 423 | 0.120 |
Why?
|
| Cefixime | 1 | 2013 | 1 | 0.120 |
Why?
|
| Ceftizoxime | 1 | 2013 | 2 | 0.120 |
Why?
|
| Insurance, Health | 1 | 2014 | 120 | 0.120 |
Why?
|
| Antibodies, Bacterial | 4 | 2012 | 107 | 0.120 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2017 | 260 | 0.120 |
Why?
|
| Continuity of Patient Care | 1 | 2014 | 90 | 0.120 |
Why?
|
| Education, Medical | 1 | 2014 | 97 | 0.120 |
Why?
|
| Research Personnel | 1 | 2014 | 133 | 0.120 |
Why?
|
| Biliary Tract Surgical Procedures | 1 | 2013 | 1 | 0.120 |
Why?
|
| Gallbladder | 1 | 2013 | 3 | 0.120 |
Why?
|
| Gallbladder Diseases | 1 | 2013 | 3 | 0.120 |
Why?
|
| Hepatectomy | 1 | 2013 | 10 | 0.110 |
Why?
|
| Research | 1 | 2014 | 159 | 0.110 |
Why?
|
| Analysis of Variance | 1 | 2014 | 528 | 0.110 |
Why?
|
| Inflammation | 1 | 2017 | 577 | 0.110 |
Why?
|
| Directly Observed Therapy | 1 | 2012 | 2 | 0.110 |
Why?
|
| National Health Programs | 1 | 2012 | 18 | 0.110 |
Why?
|
| Zoonoses | 1 | 2012 | 19 | 0.110 |
Why?
|
| Antitubercular Agents | 1 | 2012 | 27 | 0.110 |
Why?
|
| Trigeminal Neuralgia | 1 | 2012 | 2 | 0.110 |
Why?
|
| Cholangiocarcinoma | 1 | 2012 | 6 | 0.110 |
Why?
|
| Population Growth | 1 | 2012 | 8 | 0.110 |
Why?
|
| Cholesterol | 2 | 2020 | 194 | 0.110 |
Why?
|
| Mammals | 1 | 2012 | 96 | 0.100 |
Why?
|
| Tuberculosis | 1 | 2012 | 56 | 0.100 |
Why?
|
| Meningococcal Infections | 1 | 2011 | 3 | 0.100 |
Why?
|
| Forecasting | 1 | 2012 | 124 | 0.100 |
Why?
|
| Algorithms | 1 | 2014 | 435 | 0.100 |
Why?
|
| Culture Media | 1 | 2011 | 84 | 0.100 |
Why?
|
| Recreation | 1 | 2011 | 29 | 0.100 |
Why?
|
| Smoking | 1 | 2018 | 903 | 0.100 |
Why?
|
| Time Factors | 4 | 2021 | 1681 | 0.100 |
Why?
|
| Models, Statistical | 1 | 2012 | 171 | 0.100 |
Why?
|
| Family | 1 | 2012 | 162 | 0.100 |
Why?
|
| Patient Education as Topic | 1 | 2012 | 207 | 0.090 |
Why?
|
| Professional Autonomy | 1 | 2010 | 4 | 0.090 |
Why?
|
| Telemedicine | 1 | 2013 | 163 | 0.090 |
Why?
|
| Nursing Staff | 1 | 2010 | 8 | 0.090 |
Why?
|
| Nurse's Role | 1 | 2010 | 31 | 0.090 |
Why?
|
| Papillomavirus Infections | 1 | 2014 | 316 | 0.090 |
Why?
|
| New York | 1 | 2010 | 69 | 0.090 |
Why?
|
| Animals | 3 | 2020 | 14307 | 0.090 |
Why?
|
| Reproducibility of Results | 2 | 2003 | 901 | 0.090 |
Why?
|
| Electrocardiography | 2 | 2020 | 154 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2012 | 147 | 0.090 |
Why?
|
| Anxiety | 1 | 2016 | 705 | 0.090 |
Why?
|
| Student Health Services | 1 | 2009 | 10 | 0.090 |
Why?
|
| Contraception, Postcoital | 1 | 2009 | 9 | 0.090 |
Why?
|
| Thoracic Neoplasms | 1 | 2009 | 2 | 0.090 |
Why?
|
| Agglutination Tests | 2 | 2012 | 5 | 0.090 |
Why?
|
| Feasibility Studies | 2 | 2006 | 196 | 0.090 |
Why?
|
| Health Planning Guidelines | 2 | 2009 | 8 | 0.090 |
Why?
|
| Focus Groups | 2 | 2017 | 307 | 0.090 |
Why?
|
| Statistics, Nonparametric | 2 | 2006 | 106 | 0.090 |
Why?
|
| Rupture, Spontaneous | 1 | 2008 | 8 | 0.090 |
Why?
|
| Asthma | 1 | 2013 | 363 | 0.090 |
Why?
|
| Appendectomy | 1 | 2008 | 16 | 0.090 |
Why?
|
| Hospitals, Pediatric | 1 | 2008 | 19 | 0.090 |
Why?
|
| Mortality | 2 | 2020 | 150 | 0.080 |
Why?
|
| Internship and Residency | 1 | 2010 | 121 | 0.080 |
Why?
|
| Research Design | 3 | 2017 | 292 | 0.080 |
Why?
|
| Drug Utilization | 1 | 2007 | 29 | 0.080 |
Why?
|
| Blood Chemical Analysis | 1 | 2007 | 19 | 0.080 |
Why?
|
| Monitoring, Physiologic | 1 | 2007 | 35 | 0.080 |
Why?
|
| Leptospira interrogans | 1 | 2007 | 1 | 0.080 |
Why?
|
| Myocardial Infarction | 2 | 2020 | 221 | 0.080 |
Why?
|
| Drug Prescriptions | 1 | 2007 | 42 | 0.080 |
Why?
|
| Disease Progression | 2 | 2009 | 580 | 0.080 |
Why?
|
| Hypertension | 1 | 2014 | 770 | 0.080 |
Why?
|
| Remission Induction | 1 | 2006 | 18 | 0.080 |
Why?
|
| Dengue | 1 | 2008 | 93 | 0.070 |
Why?
|
| Prostate-Specific Antigen | 1 | 2007 | 95 | 0.070 |
Why?
|
| Faculty | 1 | 2007 | 82 | 0.070 |
Why?
|
| Motor Activity | 1 | 2009 | 393 | 0.070 |
Why?
|
| Disasters | 1 | 2007 | 64 | 0.070 |
Why?
|
| Professional Role | 1 | 2006 | 38 | 0.070 |
Why?
|
| Morbidity | 2 | 2018 | 94 | 0.070 |
Why?
|
| Bone Neoplasms | 1 | 2006 | 42 | 0.070 |
Why?
|
| Aging | 2 | 2020 | 639 | 0.070 |
Why?
|
| Psychiatry | 1 | 2005 | 24 | 0.070 |
Why?
|
| Seroepidemiologic Studies | 2 | 2017 | 67 | 0.070 |
Why?
|
| Lipoproteins | 1 | 2005 | 61 | 0.070 |
Why?
|
| Triglycerides | 1 | 2005 | 129 | 0.060 |
Why?
|
| Brain Neoplasms | 1 | 2006 | 105 | 0.060 |
Why?
|
| Epidemiologic Research Design | 1 | 2004 | 16 | 0.060 |
Why?
|
| Workload | 1 | 2004 | 22 | 0.060 |
Why?
|
| Public Health Administration | 1 | 2004 | 25 | 0.060 |
Why?
|
| Social Perception | 1 | 2005 | 59 | 0.060 |
Why?
|
| Pacific Islands | 1 | 2004 | 115 | 0.060 |
Why?
|
| Bacteriological Techniques | 1 | 2004 | 13 | 0.060 |
Why?
|
| Coronary Disease | 1 | 2005 | 113 | 0.060 |
Why?
|
| Prospective Studies | 3 | 2017 | 1353 | 0.060 |
Why?
|
| Censuses | 1 | 2004 | 24 | 0.060 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2004 | 22 | 0.060 |
Why?
|
| Developing Countries | 1 | 2004 | 97 | 0.060 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2006 | 176 | 0.060 |
Why?
|
| Meconium | 1 | 2003 | 10 | 0.060 |
Why?
|
| Nova Scotia | 1 | 2023 | 4 | 0.060 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2004 | 47 | 0.060 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2003 | 29 | 0.060 |
Why?
|
| Medically Underserved Area | 1 | 2004 | 98 | 0.060 |
Why?
|
| Women's Health | 1 | 2004 | 135 | 0.060 |
Why?
|
| Serotyping | 1 | 2003 | 36 | 0.060 |
Why?
|
| Cotinine | 1 | 2003 | 40 | 0.060 |
Why?
|
| Adenocarcinoma | 1 | 2006 | 239 | 0.060 |
Why?
|
| Radiotherapy Dosage | 3 | 2009 | 8 | 0.060 |
Why?
|
| Urinalysis | 1 | 2003 | 31 | 0.060 |
Why?
|
| Homosexuality, Male | 2 | 2023 | 438 | 0.060 |
Why?
|
| Epidemiologic Studies | 1 | 2003 | 31 | 0.060 |
Why?
|
| Physician-Nurse Relations | 1 | 2002 | 3 | 0.060 |
Why?
|
| Serologic Tests | 1 | 2003 | 43 | 0.060 |
Why?
|
| Fatty Acids | 1 | 2003 | 118 | 0.060 |
Why?
|
| Neuropsychological Tests | 1 | 2023 | 255 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2003 | 211 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2003 | 233 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2018 | 322 | 0.050 |
Why?
|
| Disease Reservoirs | 1 | 2002 | 20 | 0.050 |
Why?
|
| Cities | 1 | 2022 | 61 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2020 | 375 | 0.050 |
Why?
|
| Paralysis | 1 | 2021 | 4 | 0.050 |
Why?
|
| Parturition | 1 | 2021 | 22 | 0.050 |
Why?
|
| Geography | 1 | 2021 | 86 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2022 | 141 | 0.050 |
Why?
|
| Prescription Drugs | 1 | 2021 | 31 | 0.050 |
Why?
|
| Reoperation | 1 | 2020 | 22 | 0.050 |
Why?
|
| Health Behavior | 1 | 2005 | 491 | 0.050 |
Why?
|
| Polypharmacy | 1 | 2021 | 27 | 0.050 |
Why?
|
| Risk Management | 1 | 2020 | 8 | 0.050 |
Why?
|
| Vasodilator Agents | 1 | 2020 | 54 | 0.050 |
Why?
|
| Gestational Age | 1 | 2021 | 190 | 0.050 |
Why?
|
| Hospitals, Urban | 2 | 2014 | 38 | 0.050 |
Why?
|
| Tobacco Use Disorder | 1 | 2003 | 229 | 0.050 |
Why?
|
| Emigrants and Immigrants | 1 | 2021 | 125 | 0.050 |
Why?
|
| Viral Load | 1 | 2021 | 300 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2022 | 841 | 0.040 |
Why?
|
| Alcohol Drinking | 1 | 2003 | 490 | 0.040 |
Why?
|
| Risk-Taking | 2 | 2017 | 435 | 0.040 |
Why?
|
| Group Processes | 1 | 2018 | 21 | 0.040 |
Why?
|
| Congresses as Topic | 1 | 2018 | 38 | 0.040 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2009 | 37 | 0.040 |
Why?
|
| Needle Sharing | 1 | 2017 | 10 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 114 | 0.040 |
Why?
|
| Mental Health | 1 | 2021 | 270 | 0.040 |
Why?
|
| User-Computer Interface | 1 | 2017 | 62 | 0.040 |
Why?
|
| Point-of-Care Systems | 1 | 2017 | 26 | 0.040 |
Why?
|
| Hepacivirus | 1 | 2017 | 59 | 0.040 |
Why?
|
| Bayes Theorem | 1 | 2017 | 91 | 0.040 |
Why?
|
| Cultural Diversity | 1 | 2018 | 158 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 247 | 0.040 |
Why?
|
| Patient Selection | 1 | 2018 | 154 | 0.040 |
Why?
|
| Genome, Bacterial | 1 | 2017 | 114 | 0.040 |
Why?
|
| Capitation Fee | 1 | 2016 | 3 | 0.040 |
Why?
|
| Fee-for-Service Plans | 1 | 2016 | 16 | 0.030 |
Why?
|
| Stroke | 1 | 2019 | 274 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1056 | 0.030 |
Why?
|
| Health Expenditures | 1 | 2016 | 30 | 0.030 |
Why?
|
| Professional Competence | 1 | 2015 | 34 | 0.030 |
Why?
|
| School Health Services | 1 | 2016 | 77 | 0.030 |
Why?
|
| Immunoglobulin M | 2 | 2008 | 81 | 0.030 |
Why?
|
| Information Dissemination | 1 | 2015 | 58 | 0.030 |
Why?
|
| Hospitals, Rural | 1 | 2014 | 19 | 0.030 |
Why?
|
| Attitude | 1 | 2015 | 97 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2008 | 445 | 0.030 |
Why?
|
| Phylogeny | 1 | 2017 | 612 | 0.030 |
Why?
|
| Models, Economic | 1 | 2013 | 18 | 0.030 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2013 | 51 | 0.030 |
Why?
|
| Bronchitis | 1 | 2013 | 5 | 0.030 |
Why?
|
| Emergencies | 1 | 2013 | 23 | 0.030 |
Why?
|
| Cost-Benefit Analysis | 1 | 2013 | 142 | 0.030 |
Why?
|
| Tuberculosis, Multidrug-Resistant | 1 | 2012 | 4 | 0.030 |
Why?
|
| Budgets | 1 | 2012 | 10 | 0.030 |
Why?
|
| World Health Organization | 1 | 2012 | 30 | 0.030 |
Why?
|
| Bile Duct Neoplasms | 1 | 2012 | 3 | 0.030 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2012 | 4 | 0.030 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2012 | 4 | 0.030 |
Why?
|
| Chi-Square Distribution | 1 | 2012 | 213 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2013 | 74 | 0.030 |
Why?
|
| Family Relations | 1 | 2012 | 45 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2013 | 206 | 0.030 |
Why?
|
| Feces | 1 | 2012 | 110 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2013 | 183 | 0.030 |
Why?
|
| Colonoscopy | 1 | 2012 | 98 | 0.030 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2011 | 20 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2003 | 555 | 0.020 |
Why?
|
| Gynecology | 1 | 2011 | 31 | 0.020 |
Why?
|
| Obstetrics | 1 | 2011 | 38 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2012 | 210 | 0.020 |
Why?
|
| Delegation, Professional | 1 | 2010 | 1 | 0.020 |
Why?
|
| Job Satisfaction | 1 | 2010 | 9 | 0.020 |
Why?
|
| Nursing Evaluation Research | 1 | 2010 | 12 | 0.020 |
Why?
|
| Employment | 1 | 2010 | 73 | 0.020 |
Why?
|
| Social Support | 1 | 2012 | 356 | 0.020 |
Why?
|
| Pregnancy, Unplanned | 1 | 2009 | 28 | 0.020 |
Why?
|
| Liver | 1 | 2012 | 447 | 0.020 |
Why?
|
| Substance-Related Disorders | 1 | 2016 | 685 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2012 | 292 | 0.020 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2008 | 4 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2009 | 104 | 0.020 |
Why?
|
| Drug Utilization Review | 1 | 2007 | 7 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2009 | 160 | 0.020 |
Why?
|
| Unsafe Sex | 1 | 2009 | 161 | 0.020 |
Why?
|
| Doxycycline | 1 | 2007 | 30 | 0.020 |
Why?
|
| Radiotherapy, Computer-Assisted | 1 | 2006 | 1 | 0.020 |
Why?
|
| Antineoplastic Protocols | 1 | 2006 | 1 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2006 | 79 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2006 | 65 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2008 | 628 | 0.020 |
Why?
|
| Fasting | 1 | 2005 | 50 | 0.020 |
Why?
|
| Cholesterol, LDL | 1 | 2005 | 63 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 2005 | 87 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2006 | 206 | 0.020 |
Why?
|
| Hospitals, Maternity | 1 | 2003 | 4 | 0.020 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2003 | 10 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2004 | 212 | 0.020 |
Why?
|
| Medical History Taking | 1 | 2003 | 33 | 0.010 |
Why?
|
| Latex Fixation Tests | 1 | 2002 | 1 | 0.010 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2002 | 14 | 0.010 |
Why?
|
| Attitude to Health | 1 | 2005 | 311 | 0.010 |
Why?
|
| Acute Disease | 1 | 2002 | 141 | 0.010 |
Why?
|
| Health Education | 1 | 2005 | 304 | 0.010 |
Why?
|